arrow
M

María C. Puertas

irsicaixa
H指数:34
被引数:4,144

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-line dolutegravir/lamivudine in HIV-1 infection: lymph node penetration and reservoir decline in a randomized open-label clinical trial

HIV-1感染中一线多替拉韦/拉米夫定治疗:一项随机开放标签临床试验中的淋巴结渗透和病毒库下降

2026-10-020
OA
Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery

揭示ART抑制的HIV感染者中正常CD4恢复背景下低CD4/CD8比率背后的CD8 T细胞代谢异常和稳态增殖

2025-09-080
OA
Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood

度鲁特韦联合拉米夫定一线抗逆转录病毒治疗对外周血人类免疫缺陷病病毒1型储库和炎症标志物的影响

2024-10-280
PRE
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission
2024-06-063
OAAI
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy

奥贝法莫德对接受抑制性抗逆转录病毒治疗的人类免疫缺陷病毒患者的病毒持久性,炎症和免疫激活的影响

2023-07-035
OAAI
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

3BNC117和romidepsin在HIV-1患者抗逆转录病毒治疗开始时的早期干预: 1b/2a期随机试验

2022-10-1752
OA
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control

肠道菌群特征与HIV-1储库大小和病毒血症控制有关

2022-04-1131
OAAI
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome

kick-and-kill治疗性疫苗BCN02临床试验中的表观遗传景观与抗逆转录病毒治疗中断 (ATI) 结果相关

2022-04-016
OAAI
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+T-cell-mediated immune control in adults
2021-11-1813
OAAI
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy

在接受达沙替尼和抗逆转录病毒治疗的HIV-1感染者中,前病毒再激活受到损害

2021-10-0114
OAAI
Early Initiation of Antiretroviral Therapy Following In Utero HIV Infection Is Associated With Low Viral Reservoirs but Other Factors Determine Viral Rebound

子宫内HIV感染后早期开始抗逆转录病毒治疗与低病毒储库有关,但其他因素决定了病毒反弹

2021-05-0714
OAAI